Disease Intelligence
As part of its Infectious Disease Analytics (IDA) solution, Airfinity offers more comprehensive analysis of disease burden and its interaction with market indicators via bi-annual disease-specific intelligence reports and briefings, as well as email alerts.
Along with high-level summaries of answers to key questions in the area, you can expect detailed analysis across:
Disease Burden: Global, regional and country-level disease burden forecasts and estimates of true incidence, including demographic breakdowns.
Pipeline: Overview of the development landscape, assessments of candidates in the pipeline, estimated approval dates, and latest efficacy results.
Commercial: Projected market segmentation and funding landscape, growth and size, including forecasted demand scenarios.
Fill out the form and tell us which disease areas you’re interested in. A member of the team will be in touch with more information about how to subscribe and access the reports.
Get In Touch!
We’ll need a few short details about you and your business.
Get In Touch!
We’ll need a few short details about you and your business.
What our users say?
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”
Director General,
IFPMA
“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”
James Fransham, Data Journalist,
The Economist